Anzahl der Publikationen: 32
Zeitschriftenartikel
Guenther, Michael; Surendran, Sai Agash; Haas, Michael; Heinemann, Volker; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Engel, Jutta; Werner, Jens; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127 und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2023):
TPX2 expression as a negative predictor of gemcitabine efficacy in pancreatic cancer.
In: British Journal of Cancer, Bd. 129: S. 175-182
[PDF, 1MB]
Ruzicka, Michael ORCID: https://orcid.org/0000-0002-2451-1070; Wurm, Sonja ORCID: https://orcid.org/0000-0002-7540-737X; Lindner, Lars H. ORCID: https://orcid.org/0000-0003-3708-8264; Dreyling, Martin ORCID: https://orcid.org/0000-0002-0358-5249; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Boeck, Stefan ORCID: https://orcid.org/0000-0002-1922-2127; Giessen-Jung, Clemens; Milani, Valeria; Stemmler, Joachim H. ORCID: https://orcid.org/0000-0001-8751-8555; Subklewe, Marion ORCID: https://orcid.org/0000-0001-9154-9469; Weigert, Oliver ORCID: https://orcid.org/0000-0002-0987-7373 und Spiekermann, Karsten ORCID: https://orcid.org/0000-0002-5139-4957
(2022):
Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia.
In: Infection, Bd. 51, Nr. 1: S. 231-238
[PDF, 723kB]
Guenther, Michael; Gil, Lina; Surendran, Sai Agash; Palm, Melanie Alexandra; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Mayerle, Julia; Engel, Jutta; Werner, Jens; Boeck, Stefan und Ormanns, Steffen ORCID: https://orcid.org/0000-0002-0754-9034
(2022):
Bacterial Lipopolysaccharide as a Negative Predictor of Adjuvant Gemcitabine Efficacy in Pancreatic Cancer.
In: JNCI Cancer Spectrum, Bd. 6, Nr. 3, pkac039
[PDF, 555kB]
Mümmler, Carlo; Zhang, Danmei; Zimmermann, Andreas; Mertsch, Pontus; Fischer, Luca; Greither, Margarete; Khatamzas, Elham; Ormanns, Steffen; Heiß-Neumann, Marion; Dreyling, Martin; Bergwelt-Baildon, Michael von und Boeck, Stefan
(2021):
Rituximab Treatment of Hairy Cell Leukemia in a Patient with Mycobacterium kansasii Infection: A Case Report.
In: Oncology Research and Treatment, Bd. 44, Nr. 11: S. 637-640
Kunzmann, Volker; Siveke, Jens T.; Alguel, Hana; Goekkurt, Eray; Siegler, Gabriele; Martens, Uwe; Waldschmidt, Dirk; Pelzer, Uwe; Fuchs, Martin; Kullmann, Frank; Boeck, Stefan; Ettrich, Thomas J.; Held, Swantje; Keller, Ralph; Klein, Ingo; Germer, Christoph-Thomas; Stein, Hubert; Friess, Helmut; Bahra, Marcus; Jakobs, Ralf; Hartlapp, Ingo und Heinemann, Volker
(2021):
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
In: Lancet Gastroenterology & Hepatology, Bd. 6, Nr. 2: S. 128-138
Gebauer, Leonie; Moltz, Jan H.; Mühlberg, Alexander; Holch, Julian W.; Huber, Thomas; Enke, Johanna; Jäger, Nils; Haas, Michael; Kruger, Stephan; Boeck, Stefan; Sühling, Michael; Katzmann, Alexander; Hahn, Horst; Kunz, Wolfgang G.; Heinemann, Volker; Noerenberg, Dominik und Maurus, Stefan
(2021):
Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer.
In: Cancers, Bd. 13, Nr. 22, 5732
Bösch, Florian; Altendorf-Hofmann, Annelore; Jacob, Sven; Auernhammer, Christoph J.; Spitzweg, Christine; Boeck, Stefan; Schubert-Fritschle, Gabriele; Werner, Jens; Kirchner, Thomas; Angele, Martin K. und Knösel, Thomas
(2020):
Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor.
In: Journal of Clinical Medicine, Bd. 9, Nr. 10, 3368
Mahajan, Ujjwal M.; Goni, Elisabetta; Langhoff, Enno; Li, Qi; Costello, Eithne; Greenhalf, William; Kruger, Stephan; Ormanns, Steffen; Halloran, Christopher; Ganeh, Paula; Marron, Manuela; Laemmerhirt, Felix; Zhao, Yue; Beyer, Georg; Weiss, Frank-Ulrich; Sendler, Matthias; Bruns, Christiane J.; Kohlmann, Thomas; Kirchner, Thomas; Werner, Jens; D'Haese, Jan G.; Bergwelt, Michael von; Heinemann, Volker; Neoptolemos, John P.; Buechler, Markus W.; Belka, Claus; Boeck, Stefan; Lerch, Markus M. und Mayerle, Julia
(2020):
Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.
In: Jnci Cancer Spectrum, Bd. 4, Nr. 1, pkz060
Guenther, Michael; Haas, Michael; Heinemann, Volker; Kruger, Stephan; Westphalen, Christoph Benedikt; Bergwelt-Baildon, Michael von; Mayerle, Julia; Werner, Jens; Kirchner, Thomas; Boeck, Stefan und Ormanns, Steffen
(2020):
Bacterial lipopolysaccharide as negative predictor of gemcitabine efficacy in advanced pancreatic cancer - translational results from the AIO-PK0104 Phase 3 study.
In: British Journal of Cancer, Bd. 123, Nr. 9: S. 1370-1376
Kruger, Stephan; Schirle, Karoline; Haas, Michael; Crispin, Alexander; Schirra, Jörg; Mayerle, Julia; D'Haese, Jan G.; Kunz, Wolfgang G.; Ricke, Jens; Ormanns, Steffen; Kirchner, Thomas; Kobold, Sebastian; Ilmer, Matthias; Gebauer, Leonie; Westphalen, Christoph B.; Bergwelt-Baildon, Michael von; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2020):
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.
In: Journal of Cancer Research and Clinical Oncology, Bd. 146, Nr. 2: S. 391-399
Bösch, Florian; Brüwer, Katharina; Altendorf-Hofmann, Annelore; Auernhammer, Christoph J.; Spitzweg, Christine; Westphalen, Benedikt; Boeck, Stefan; Schubert-Fritschle, Gabriele; Werner, Jens; Heinemann, Volker; Kirchner, Thomas; Angele, Martin K. und Knösel, Thomas
(2019):
Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.
In: Endocrine-Related Cancer, Bd. 26, Nr. 3: S. 293-301
Ormanns, Steffen; Haas, Michael; Remold, Anna; Kruger, Stephan; Holdenrieder, Stefan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2017):
The Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic Chemotherapy.
In: International Journal of Molecular Sciences, Bd. 18, Nr. 5, 1094
[PDF, 1MB]
Kruger, Stephan; Legenstein, Marie-Louise; Rösgen, Verena; Haas, Michael; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Ormanns, Steffen; Kirchner, Thomas; Heinemann, Volker; Holdenrieder, Stefan und Boeck, Stefan
(2017):
Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.
In: Oncoimmunology, Bd. 6, Nr. 5, e1310358
Kruger, Stephan; Haas, Michael; Burkl, Carolin; Goehring, Peter; Kleespies, Axel; Röder, Falk; Gallmeier, Eike; Ormanns, Steffen; Westphalen, Christoph Benedikt; Heinemann, Volker; Rank, Andreas und Boeck, Stefan
(2017):
Incidence, outcome and risk stratification tools for venous thromboembolism in advanced pancreatic cancer - A retrospective cohort study.
In: Thrombosis Research, Bd. 157: S. 9-15
Mich, Marlies; Lehner, Sebastian; Paprottka, Philipp M.; Ilhan, Harun; Bartenstein, Peter; Heinemann, Volker; Boeck, Stefan; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624 und Fendler, Wolfgang P.
(2016):
Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer.
In: Journal of Nuclear Medicine, Bd. 57, Nr. 3: S. 355-360
Ormanns, Steffen; Haas, Michael; Baechmann, Sibylle; Altendorf-Hofmann, Annelore; Remold, Anna; Quietzsch, Detlef; Clemens, Michael R.; Bentz, Martin; Geissler, Michael; Lambertz, Helmut; Kruger, Stephan; Kirchner, Thomas; Heinemann, Volker und Boeck, Stefan
(2016):
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
In: British Journal of Cancer, Bd. 115, Nr. 12: S. 1520-1529
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 142, Nr. 12: S. 2585-2591
Renz, Bernhard W.; Khalil, Philippe N.; Mikhailov, Michael; Graf, Sandra; Schiergens, Tobias S.; Niess, Hanno; Boeck, Stefan; Heinemann, Volker; Hartwig, Werner; Werner, Jens; Bruns, Christiane J. und Kleespies, Axel
(2016):
Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.
In: International Journal of Surgery, Bd. 28: S. 118-125
Kruger, Stephan; Haas, Michael; Burger, Philipp Johannes; Ormanns, Steffen; Modest, Dominik Paul; Westphalen, Christoph Benedikt; Michl, Marlies; Kleespies, Axel; Angele, Martin Kurt; Hartwig, Werner; Bruns, Christiane Josephine; Niyazi, Maximilian; Roeder, Falk; Kirchner, Thomas; Werner, Jens; Heinemann, Volker und Boeck, Stefan
(2016):
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancer.
In: Pancreatology, Bd. 16, Nr. 4: S. 593-598
Steffens, Michael; Paul, Tanusree; Hichert, Vivien; Scholl, Catharina; Mallek, Dirk von; Stelzer, Christoph; Sörgel, Fritz; Reiser, Bärbel; Schumann, Christian; Rüdiger, Stefan; Boeck, Stefan; Heinemann, Volker; Kächele, Volker; Seufferlein, Thomas und Stingl, Julia
(2016):
Dosing to rash? - The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.
In: European Journal of Cancer, Bd. 55: S. 131-139
Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J. und Modest, Dominik P.
(2015):
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
In: Anti-Cancer Drugs, Bd. 26, Nr. 4: S. 371-378
[PDF, 251kB]
Joka, Mareile; Boeck, Stefan; Zech, Christoph J.; Seufferlein, Thomas; Wichert, Götz von; Licht, Thomas; Krause, Annekatrin; Jauch, Karl-Walter; Heinemann, Volker und Bruns, Christiane J.
(2014):
Combination of antiangiogenic therapy using the mTOR-inhibitor everolimus and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: a dose-finding study.
In: Anti-Cancer Drugs, Bd. 25, Nr. 9: S. 1095-1101
[PDF, 364kB]
Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas und Boeck, Stefan
(2014):
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
In: BMC Cancer
14:624
[PDF, 408kB]
Boeck, Stefan; Wilkowski, Ralf; Bruns, Christiane J.; Issels, Rolf-Dieter; Schulz, Christoph; Moosmann, Nicolas; Laessig, Dorit; Haas, Michael; Golf, Alexander und Heinemann, Volker
(2007):
Oral capecitabine in gemcitabine-pretreated patients with advanced pancreatic cancer.
In: Oncology, Nr. 3-4: S. 221-227
[PDF, 330kB]
Diese Liste wurde am
Sat Mar 23 20:18:49 2024 CET
erstellt.